UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:PCTP-BRIP1 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: PCTP-BRIP1 | FusionPDB ID: 63541 | FusionGDB2.0 ID: 63541 | Hgene | Tgene | Gene symbol | PCTP | BRIP1 | Gene ID | 58488 | 83990 |
Gene name | phosphatidylcholine transfer protein | BRCA1 interacting protein C-terminal helicase 1 | |
Synonyms | PC-TP|STARD2 | BACH1|FANCJ|OF | |
Cytomap | 17q22 | 17q23.2 | |
Type of gene | protein-coding | protein-coding | |
Description | phosphatidylcholine transfer proteinSTART domain-containing protein 2StAR-related lipid transfer (START) domain containing 2stAR-related lipid transfer protein 2 | Fanconi anemia group J proteinATP-dependent RNA helicase BRIP1BRCA1-associated C-terminal helicase 1BRCA1-binding helicase-like protein BACH1BRCA1/BRCA2-associated helicase 1 | |
Modification date | 20200313 | 20200315 | |
UniProtAcc | . | Q9BX63 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000268896, ENST00000573500, ENST00000576183, ENST00000325214, ENST00000576221, | ENST00000583837, ENST00000259008, ENST00000577598, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 6 X 3 X 5=90 | 12 X 15 X 7=1260 |
# samples | 7 | 13 | |
** MAII score | log2(7/90*10)=-0.362570079384708 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(13/1260*10)=-3.27684020535882 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: PCTP [Title/Abstract] AND BRIP1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | PCTP(53828605)-BRIP1(59861785), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | PCTP-BRIP1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. PCTP-BRIP1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. PCTP-BRIP1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. PCTP-BRIP1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PCTP | GO:0015914 | phospholipid transport | 12055623 |
Tgene | BRIP1 | GO:0006357 | regulation of transcription by RNA polymerase II | 14504288 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | SARC | TCGA-IE-A3OV-01A | PCTP | chr17 | 53828605 | + | BRIP1 | chr17 | 59861785 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000573500 | PCTP | chr17 | 53828605 | + | ENST00000259008 | BRIP1 | chr17 | 59861785 | - | 4458 | 151 | 10 | 2427 | 805 |
ENST00000573500 | PCTP | chr17 | 53828605 | + | ENST00000577598 | BRIP1 | chr17 | 59861785 | - | 2647 | 151 | 10 | 1662 | 550 |
ENST00000268896 | PCTP | chr17 | 53828605 | + | ENST00000259008 | BRIP1 | chr17 | 59861785 | - | 4573 | 266 | 89 | 2542 | 817 |
ENST00000268896 | PCTP | chr17 | 53828605 | + | ENST00000577598 | BRIP1 | chr17 | 59861785 | - | 2762 | 266 | 89 | 1777 | 562 |
ENST00000576183 | PCTP | chr17 | 53828605 | + | ENST00000259008 | BRIP1 | chr17 | 59861785 | - | 4491 | 184 | 7 | 2460 | 817 |
ENST00000576183 | PCTP | chr17 | 53828605 | + | ENST00000577598 | BRIP1 | chr17 | 59861785 | - | 2680 | 184 | 7 | 1695 | 562 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000573500 | ENST00000259008 | PCTP | chr17 | 53828605 | + | BRIP1 | chr17 | 59861785 | - | 0.000458302 | 0.99954176 |
ENST00000573500 | ENST00000577598 | PCTP | chr17 | 53828605 | + | BRIP1 | chr17 | 59861785 | - | 0.000565195 | 0.99943477 |
ENST00000268896 | ENST00000259008 | PCTP | chr17 | 53828605 | + | BRIP1 | chr17 | 59861785 | - | 0.000462182 | 0.9995378 |
ENST00000268896 | ENST00000577598 | PCTP | chr17 | 53828605 | + | BRIP1 | chr17 | 59861785 | - | 0.000589687 | 0.9994103 |
ENST00000576183 | ENST00000259008 | PCTP | chr17 | 53828605 | + | BRIP1 | chr17 | 59861785 | - | 0.000466956 | 0.99953306 |
ENST00000576183 | ENST00000577598 | PCTP | chr17 | 53828605 | + | BRIP1 | chr17 | 59861785 | - | 0.00059627 | 0.9994037 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >63541_63541_1_PCTP-BRIP1_PCTP_chr17_53828605_ENST00000268896_BRIP1_chr17_59861785_ENST00000259008_length(amino acids)=817AA_BP=59 MPSRRRSPDCGRMELAAGSFSEEQFWEACAELQQPALAGADWQLLVETSGISIYRLLDKGHFSAVLQKEEKISPIYGKEEAREVPVISAS TQIMLKGLFMVLDYLFRQNSRFADDYKIAIQQTYSWTNQIDISDKNGLLVLPKNKKRSRQKTAVHVLNFWCLNPAVAFSDINGKVQTIVL TSGTLSPMKSFSSELGVTFTIQLEANHIIKNSQVWVGTIGSGPKGRNLCATFQNTETFEFQDEVGALLLSVCQTVSQGILCFLPSYKLLE KLKERWLSTGLWHNLELVKTVIVEPQGGEKTNFDELLQVYYDAIKYKGEKDGALLVAVCRGKVSEGLDFSDDNARAVITIGIPFPNVKDL QVELKRQYNDHHSKLRGLLPGRQWYEIQAYRALNQALGRCIRHRNDWGALILVDDRFRNNPSRYISGLSKWVRQQIQHHSTFESALESLA EFSKKHQKVLNVSIKDRTNIQDNESTLEVTSLKYSTSPYLLEAASHLSPENFVEDEAKICVQELQCPKIITKNSPLPSSIISRKEKNDPV FLEEAGKAEKIVISRSTSPTFNKQTKRVSWSSFNSLGQYFTGKIPKATPELGSSENSASSPPRFKTEKMESKTVLPFTDKCESSNLTVNT SFGSCPQSETIISSLKIDATLTRKNHSEHPLCSEEALDPDIELSLVSEEDKQSTSNRDFETEAEDESIYFTPELYDPEDTDEEKNDLAET DRGNRLANNSDCILAKDLFEIRTIKEVDSAREVKAEDCIDTKLNGILHIEESKIDDIDGNVKTTWINELELGKTHEIEIKNFKPSPSKNK -------------------------------------------------------------- >63541_63541_2_PCTP-BRIP1_PCTP_chr17_53828605_ENST00000268896_BRIP1_chr17_59861785_ENST00000577598_length(amino acids)=562AA_BP=59 MPSRRRSPDCGRMELAAGSFSEEQFWEACAELQQPALAGADWQLLVETSGISIYRLLDKGHFSAVLQKEEKISPIYGKEEAREVPVISAS TQIMLKGLFMVLDYLFRQNSRFADDYKIAIQQTYSWTNQIDISDKNGLLVLPKNKKRSRQKTAVHVLNFWCLNPAVAFSDINGKVQTIVL TSGTLSPMKSFSSELGVTFTIQLEANHIIKNSQVWVGTIGSGPKGRNLCATFQNTETFEFQDEVGALLLSVCQTVSQGILCFLPSYKLLE KLKERWLSTGLWHNLELVKTVIVEPQGGEKTNFDELLQVYYDAIKYKGEKDGALLVAVCRGKVSEGLDFSDDNARAVITIGIPFPNVKDL QVELKRQYNDHHSKLRGLLPGRQWYEIQAYRALNQALGRCIRHRNDWGALILVDDRFRNNPSRYISGLSKWVRQQIQHHSTFESALESLA EFSKKHQKVLNVSIKDRTNIQDNESTLEVTSLKYSTSPYLLEAASHLSPENFVEDEAKICVQELQCPKIITKNSPLPSSIISRKEKSMKS -------------------------------------------------------------- >63541_63541_3_PCTP-BRIP1_PCTP_chr17_53828605_ENST00000573500_BRIP1_chr17_59861785_ENST00000259008_length(amino acids)=805AA_BP=47 MELAAGSFSEEQFWEACAELQQPALAGADWQLLVETSGISIYRLLDKGHFSAVLQKEEKISPIYGKEEAREVPVISASTQIMLKGLFMVL DYLFRQNSRFADDYKIAIQQTYSWTNQIDISDKNGLLVLPKNKKRSRQKTAVHVLNFWCLNPAVAFSDINGKVQTIVLTSGTLSPMKSFS SELGVTFTIQLEANHIIKNSQVWVGTIGSGPKGRNLCATFQNTETFEFQDEVGALLLSVCQTVSQGILCFLPSYKLLEKLKERWLSTGLW HNLELVKTVIVEPQGGEKTNFDELLQVYYDAIKYKGEKDGALLVAVCRGKVSEGLDFSDDNARAVITIGIPFPNVKDLQVELKRQYNDHH SKLRGLLPGRQWYEIQAYRALNQALGRCIRHRNDWGALILVDDRFRNNPSRYISGLSKWVRQQIQHHSTFESALESLAEFSKKHQKVLNV SIKDRTNIQDNESTLEVTSLKYSTSPYLLEAASHLSPENFVEDEAKICVQELQCPKIITKNSPLPSSIISRKEKNDPVFLEEAGKAEKIV ISRSTSPTFNKQTKRVSWSSFNSLGQYFTGKIPKATPELGSSENSASSPPRFKTEKMESKTVLPFTDKCESSNLTVNTSFGSCPQSETII SSLKIDATLTRKNHSEHPLCSEEALDPDIELSLVSEEDKQSTSNRDFETEAEDESIYFTPELYDPEDTDEEKNDLAETDRGNRLANNSDC -------------------------------------------------------------- >63541_63541_4_PCTP-BRIP1_PCTP_chr17_53828605_ENST00000573500_BRIP1_chr17_59861785_ENST00000577598_length(amino acids)=550AA_BP=47 MELAAGSFSEEQFWEACAELQQPALAGADWQLLVETSGISIYRLLDKGHFSAVLQKEEKISPIYGKEEAREVPVISASTQIMLKGLFMVL DYLFRQNSRFADDYKIAIQQTYSWTNQIDISDKNGLLVLPKNKKRSRQKTAVHVLNFWCLNPAVAFSDINGKVQTIVLTSGTLSPMKSFS SELGVTFTIQLEANHIIKNSQVWVGTIGSGPKGRNLCATFQNTETFEFQDEVGALLLSVCQTVSQGILCFLPSYKLLEKLKERWLSTGLW HNLELVKTVIVEPQGGEKTNFDELLQVYYDAIKYKGEKDGALLVAVCRGKVSEGLDFSDDNARAVITIGIPFPNVKDLQVELKRQYNDHH SKLRGLLPGRQWYEIQAYRALNQALGRCIRHRNDWGALILVDDRFRNNPSRYISGLSKWVRQQIQHHSTFESALESLAEFSKKHQKVLNV SIKDRTNIQDNESTLEVTSLKYSTSPYLLEAASHLSPENFVEDEAKICVQELQCPKIITKNSPLPSSIISRKEKSMKSSSHLPLIEKSFI -------------------------------------------------------------- >63541_63541_5_PCTP-BRIP1_PCTP_chr17_53828605_ENST00000576183_BRIP1_chr17_59861785_ENST00000259008_length(amino acids)=817AA_BP=59 MPSRRRSPDCGRMELAAGSFSEEQFWEACAELQQPALAGADWQLLVETSGISIYRLLDKGHFSAVLQKEEKISPIYGKEEAREVPVISAS TQIMLKGLFMVLDYLFRQNSRFADDYKIAIQQTYSWTNQIDISDKNGLLVLPKNKKRSRQKTAVHVLNFWCLNPAVAFSDINGKVQTIVL TSGTLSPMKSFSSELGVTFTIQLEANHIIKNSQVWVGTIGSGPKGRNLCATFQNTETFEFQDEVGALLLSVCQTVSQGILCFLPSYKLLE KLKERWLSTGLWHNLELVKTVIVEPQGGEKTNFDELLQVYYDAIKYKGEKDGALLVAVCRGKVSEGLDFSDDNARAVITIGIPFPNVKDL QVELKRQYNDHHSKLRGLLPGRQWYEIQAYRALNQALGRCIRHRNDWGALILVDDRFRNNPSRYISGLSKWVRQQIQHHSTFESALESLA EFSKKHQKVLNVSIKDRTNIQDNESTLEVTSLKYSTSPYLLEAASHLSPENFVEDEAKICVQELQCPKIITKNSPLPSSIISRKEKNDPV FLEEAGKAEKIVISRSTSPTFNKQTKRVSWSSFNSLGQYFTGKIPKATPELGSSENSASSPPRFKTEKMESKTVLPFTDKCESSNLTVNT SFGSCPQSETIISSLKIDATLTRKNHSEHPLCSEEALDPDIELSLVSEEDKQSTSNRDFETEAEDESIYFTPELYDPEDTDEEKNDLAET DRGNRLANNSDCILAKDLFEIRTIKEVDSAREVKAEDCIDTKLNGILHIEESKIDDIDGNVKTTWINELELGKTHEIEIKNFKPSPSKNK -------------------------------------------------------------- >63541_63541_6_PCTP-BRIP1_PCTP_chr17_53828605_ENST00000576183_BRIP1_chr17_59861785_ENST00000577598_length(amino acids)=562AA_BP=59 MPSRRRSPDCGRMELAAGSFSEEQFWEACAELQQPALAGADWQLLVETSGISIYRLLDKGHFSAVLQKEEKISPIYGKEEAREVPVISAS TQIMLKGLFMVLDYLFRQNSRFADDYKIAIQQTYSWTNQIDISDKNGLLVLPKNKKRSRQKTAVHVLNFWCLNPAVAFSDINGKVQTIVL TSGTLSPMKSFSSELGVTFTIQLEANHIIKNSQVWVGTIGSGPKGRNLCATFQNTETFEFQDEVGALLLSVCQTVSQGILCFLPSYKLLE KLKERWLSTGLWHNLELVKTVIVEPQGGEKTNFDELLQVYYDAIKYKGEKDGALLVAVCRGKVSEGLDFSDDNARAVITIGIPFPNVKDL QVELKRQYNDHHSKLRGLLPGRQWYEIQAYRALNQALGRCIRHRNDWGALILVDDRFRNNPSRYISGLSKWVRQQIQHHSTFESALESLA EFSKKHQKVLNVSIKDRTNIQDNESTLEVTSLKYSTSPYLLEAASHLSPENFVEDEAKICVQELQCPKIITKNSPLPSSIISRKEKSMKS -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:53828605/chr17:59861785) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | BRIP1 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: DNA-dependent ATPase and 5' to 3' DNA helicase required for the maintenance of chromosomal stability. Acts late in the Fanconi anemia pathway, after FANCD2 ubiquitination. Involved in the repair of DNA double-strand breaks by homologous recombination in a manner that depends on its association with BRCA1. {ECO:0000269|PubMed:11301010, ECO:0000269|PubMed:14983014, ECO:0000269|PubMed:16116421, ECO:0000269|PubMed:16153896}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PCTP | chr17:53828605 | chr17:59861785 | ENST00000268896 | + | 1 | 6 | 1_212 | 47.0 | 215.0 | Domain | START |
Hgene | PCTP | chr17:53828605 | chr17:59861785 | ENST00000325214 | + | 1 | 6 | 1_212 | 0 | 143.0 | Domain | START |
Tgene | BRIP1 | chr17:53828605 | chr17:59861785 | ENST00000259008 | 9 | 20 | 11_442 | 491.0 | 1250.0 | Domain | Helicase ATP-binding | |
Tgene | BRIP1 | chr17:53828605 | chr17:59861785 | ENST00000259008 | 9 | 20 | 158_175 | 491.0 | 1250.0 | Motif | Nuclear localization signal | |
Tgene | BRIP1 | chr17:53828605 | chr17:59861785 | ENST00000259008 | 9 | 20 | 393_396 | 491.0 | 1250.0 | Motif | Note=DEAH box | |
Tgene | BRIP1 | chr17:53828605 | chr17:59861785 | ENST00000259008 | 9 | 20 | 185_192 | 491.0 | 1250.0 | Nucleotide binding | ATP |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
PCTP | |
BRIP1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to PCTP-BRIP1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to PCTP-BRIP1 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |